Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms
- PMID: 15283976
- DOI: 10.1016/j.biochi.2004.04.009
Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms
Abstract
Triiodothyronine (T3) and triiodothyroacetic acid (TA3) are thyroid compounds that similarly protect low-density lipoprotein (LDL) against oxidation induced by the free radical generator 2,2'-azobis-[2-amidinopropane] dihydrochloride (AAPH). However, TA3 is more antioxidant than T3 on LDL oxidation induced by copper ions (Cu2+), suggesting that these compounds act by different mechanisms. Here we measured conjugated diene production kinetics during in vitro human LDL (50 mg LDL-protein per l) oxidation induced by various Cu2+ (0.5-4 microM) or AAPH (0.25-2 mM) concentrations in the presence of T3, TA3, butylated hydroxytoluene (BHT) (a free radical scavenger) or ethylenediaminetetracetic acid (EDTA) (a metal chelator). From the kinetics were estimated: length of the lag phase (Tlag), maximum velocity of conjugated diene production (Vmax), and maximum amount of generated dienes (Dmax). Thyroid compound effects on these oxidation parameters were compared to those of the controls BHT and EDTA. In addition we measured by atomic absorption spectrometry copper remaining in LDL after a 30 min incubation of LDL with Cu2+ and the compounds followed by extensive dialysis, i.e. copper bound to LDL. As expected, LDL-copper was decreased by EDTA in a concentration-dependent manner, whereas it was not affected by BHT. T3 increased LDL-copper whereas TA3 slightly decreased it. The whole data suggest that T3 and TA3 are free radical scavengers that also differently disturb LDL-copper binding, an essential step for LDL lipid peroxidation. The most likely mechanisms are that T3 induces new copper binding sites inside the LDL particle, increasing the LDL-copper amount but in a redox-inactive form, whereas TA3 blocks some redox-active copper binding sites highly implicated in the initiation and the propagation of lipid peroxidation. Alternatively, we also found that a little amount of copper is tightly bound in LDL, which may be essential for the propagation of lipid peroxidation induced by free radical generators.
Similar articles
-
Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds.J Endocrinol. 2003 Apr;177(1):137-46. doi: 10.1677/joe.0.1770137. J Endocrinol. 2003. PMID: 12697045
-
The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.Atherosclerosis. 1998 Mar;137(1):49-61. doi: 10.1016/s0021-9150(97)00251-7. Atherosclerosis. 1998. PMID: 9568736
-
Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro.Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3255-62. doi: 10.1161/01.atv.17.11.3255. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409320
-
A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.Arch Biochem Biophys. 2001 Oct 1;394(1):117-35. doi: 10.1006/abbi.2001.2509. Arch Biochem Biophys. 2001. PMID: 11566034 Review.
-
The Potential Protective Effects of Phenolic Compounds against Low-density Lipoprotein Oxidation.Curr Pharm Des. 2017;23(19):2754-2766. doi: 10.2174/1381612823666170329142936. Curr Pharm Des. 2017. PMID: 28356039 Review.
Cited by
-
A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression.Front Med (Lausanne). 2020 May 29;7:228. doi: 10.3389/fmed.2020.00228. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32549042 Free PMC article.
-
Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment-A Single-Group Repeated-Measures Trial.Diabetes Metab Syndr Obes. 2024 May 27;17:2165-2176. doi: 10.2147/DMSO.S458486. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38827164 Free PMC article.
-
Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review.Front Endocrinol (Lausanne). 2019 Dec 10;10:868. doi: 10.3389/fendo.2019.00868. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31920978 Free PMC article. Review.
-
Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism.Sci Rep. 2016 May 19;6:26174. doi: 10.1038/srep26174. Sci Rep. 2016. PMID: 27193069 Free PMC article.
-
Study of the association between thyroid dysfunction and serum lipid abnormalities.Biomed Rep. 2024 Jul 31;21(4):138. doi: 10.3892/br.2024.1826. eCollection 2024 Oct. Biomed Rep. 2024. PMID: 39129836 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials